In this issue:
Beneficial effects of autologous MSC transplantation in active progressive MS
Efficacy and safety of 2 fingolimod doses vs glatiramer acetate for relapsing MS
Reliability of outcome measures in clinical trials in SPMS
The prevalence of HTN in MS
Dimethyl fumarate-induced lymphocyte count drop is related to effectiveness in RRMS
Concussion in adolescence and the risk of MS
Exposure to passive smoking during adolescence is associated with an increased risk of MS
Prognostic role of intrathecal IgM synthesis in MS
Cyclophosphamide in treatment of tumefactive MS
Proportion of alemtuzumab-treated patients converting from RRMS to SPMS over 6 years
Please login below to download this issue (PDF)